ADVERTISEMENT
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

cancer, FDA

First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018 | 2 min read
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
Foundation Medicine’s Cancer Gene Test Gains FDA and CMS Approval
Diana Kwon | Dec 1, 2017 | 1 min read
The Centers for Medicare and Medicaid Services propose covering the test with Medicare. 
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017 | 2 min read
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Notable Science Quotes
The Scientist | Apr 1, 2017 | 2 min read
Eugene Garfield, the cancer moonshot, employee genetic testing, and more
AACR Releases Tobacco Report
Jef Akst | Apr 7, 2014 | 2 min read
Researchers and regulators reflect on the progress that has been made in preventing tobacco-related disease in the 50 years since the publication of the first U.S. Surgeon General’s report. 
A Plea to the FDA
Cristina Luiggi | Jun 21, 2012 | 1 min read
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
FDA OKs Early Stage Trials
Cristina Luiggi | Jun 5, 2012 | 1 min read
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
More Oversight for Omics Tests
N/A | Mar 27, 2012 | 1 min read
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Genentech Plans New Avastin Trial
Tia Ghose | Nov 21, 2011 | 1 min read
After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
Take Two of These
Bob Grant | Jun 22, 2011 | 6 min read
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
ADVERTISEMENT